A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study.
Year: 1990
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: K J Tveter, S Hagen, I Holme, O Klepp, S E Kloster, O Muri, C Poulsen, S Sander, S Sivertsen, T Urnes
Institution: Oslo University Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2401603321